The American College of Obstetricians and Gynecologists (ACOG) and the Society of Gynecologic Oncologists (SGO) recommend routine assessment of a woman’s risk of hereditary breast and ovarian cancer, in order to identify those who may benefit from a more thorough hereditary cancer risk assessment. Women who eventually undergo genetic testing and are found to carry a BRCA1 or BRCA2 gene mutation have options available to manage their increased risk of cancer. These guidelines were published in Obstetrics and Gynecology.
The wife and I are currently doing this through 23andMe. Can't wait to get the results.
No comments:
Post a Comment